SCHEMBL4566559

SCHEMBL4566559

COCCn1c(-c2ccc(C(C)C)cc2)nc2c(Br)c(CN(c3ccccc3)C(O)Cc3ccccc3OCc3cc(OC)c4c(nc(-c5ccc(C(C)C)cc5)n4CCOC)c3C(F)(F)F)cc(OC)c21

nearest known ligand 0.64

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
CASR P41180 20/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2493626 0.82 CASR (0.75) CASR
SCHEMBL2502803 0.81 CASR (0.75) CASR
SCHEMBL2495672 0.80 CASR (0.76) CASR
SCHEMBL2502839 0.80 CASR (0.71) CASR
SCHEMBL2496420 0.79 CASR (1.00) CASR
SCHEMBL2501023 0.79 CASR (0.77) CASR
SCHEMBL2498074 0.78 CASR (0.69) CASR
SCHEMBL2499818 0.78 CASR (0.75) CASR
SCHEMBL2498378 0.78 CASR (0.72) CASR
SCHEMBL2494220 0.78 CASR (0.72) CASR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2124893-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A CALCILYTIC AGENT Novartis AG (CH) 2009-12-02 EP disclosed
WO-2008107390-A1 PHARMACEUTICAL COMPOSITIONS COMPRISING A CALCILYTIC AGENT NOVARTIS AG (CH) 2008-09-12 WO disclosed